Mixed Dyslipidaemia
Mixed dyslipidaemia involves abnormalities across multiple lipid fractions, including LDL, HDL, and triglycerides. These are commonly assessed together through a routine lipid profile blood test.
Key points
- Mixed dyslipidaemia encompasses elevated LDL (‘bad’) cholesterol, low HDL (‘good’) cholesterol, and raised triglycerides, all of which contribute to cardiovascular risk.
- The condition typically produces no noticeable symptoms, so it is usually detected only through blood testing.
- Management generally involves lifestyle changes such as diet and exercise, and may require medicines including statins, with additional agents like fibrates or ezetimibe if statins alone are insufficient.
Medicines listed for Mixed Dyslipidaemia
The listed products for Mixed Dyslipidaemia contain Bempedoic Acid and Fenofibrate, both in tablet form. Bempedoic acid is a non-statin agent that reduces cholesterol production in the liver, while fenofibrate is a fibrate that primarily targets triglyceride levels. These two classes address different lipid fractions involved in mixed dyslipidaemia.

